ArticleScientific reports2026
NMR metabolomic signatures of healthy lifestyle and incident MASLD.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
We aimed to investigate the relationship between metabolomic signatures of healthy lifestyle with incident metabolic dysfunction-associated steatotic liver disease (MASLD) risk, and quantify the extent to metabolic signatures explain the healthy lifestyle-MASLD relationship. This prospective cohort study analyzed 179,261 UK Biobank participants with available nuclear magnetic resonance metabolomics data. Healthy lifestyle scores incorporated dietary quality, alcohol consumption, physical activity, and smoking behavior. Elastic net regularized regression identified lifestyle-associated metabolic signatures from 251 metabolic biomarkers. Cox regression models evaluated associations between lifestyle indices, metabolic profiles, and incident MASLD. Counterfactual-based mediation analysis quantified mechanistic pathways. During follow-up, 2422 participants (1.35%) developed incident MASLD. We identified a 94-metabolite signature strongly reflecting healthy lifestyle behaviors, dominated by lipoprotein subclasses (61.70%) and fatty acids (10.64%). Each 1-unit increment in the metabolic signature corresponded to 65.9% reduced MASLD risk (HR = 0.341, 95% CI 0.311-0.373). Mediation analysis revealed that metabolic alterations explained 55.80% (95% CI 47.85-85.28%) of the protective lifestyle-MASLD association, with fatty acid metabolism contributing the largest mediation effect. Addtionly, the parallel mediating effect of metabolic signatures, BMI, diabetes, and hypertension reached 86.21%. This comprehensive metabolomic signature captures healthy lifestyle behaviors and strongly predicts incident MASLD risk through metabolic reprogramming, particularly fatty acid and lipoprotein metabolism.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.